While on this specific point he could be right unless NWBO cash burn significantly disminished, which would be great news, you are also right that the guy has left the paths of fair reporting for a long time.
His hatred toward NWBO is so much publicized that I don't see how his carreer as biotech analyst/report could continue in case DCVax-L prove its efficacy in the current large trial.
News 
Market Data 
Discover 
